Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Chamanlal Shishoo"'
Publikováno v:
Journal of Advanced Pharmaceutical Technology & Research, Vol 2, Iss 1, Pp 30-38 (2011)
A new oil-in-water microemulsion-based (ME) gel containing 1% itraconazole (ITZ) was developed for topical delivery. The solubility of ITZ in oils and surfactants was evaluated to identify potential excipients. The microemulsion existence ranges were
Externí odkaz:
https://doaj.org/article/72196c1d8fe447979d8f3ae67d9022d6
Autor:
Chamanlal Shishoo, Kamala K. Vasu, Arpan Chudasama, Manish Nivsarkar, Vineetkumar Patel, Brijesh Shah
Publikováno v:
Journal of Pharmaceutical Investigation. 45:271-283
Poorly water-soluble drug, itraconazole (ITZ) offers a challenge in developing a drug product with adequate bioavailability. The potential for lipidic self-emulsifying drug delivery system to improve the oral bioavailability of ITZ was investigated i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f9786cd62a71ef857a2dd7eb4a61474
https://doi.org/10.1007/s40005-015-0172-5
https://doi.org/10.1007/s40005-015-0172-5
Publikováno v:
Drug Delivery. 22:531-540
The objective of this study was to develop self-emulsifying drug delivery system (SEDDS) to improve solubility and enhance the oral absorption of the poorly water-soluble drug, nevirapine. This lipid-based formulation may help to target the drug to l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fed006b7c819438f5814b5af9ff726ed
https://doi.org/10.3109/10717544.2014.891270
https://doi.org/10.3109/10717544.2014.891270
Publikováno v:
Drug Delivery. 22:918-930
Alzheimer's disease (AD) is a progressive neurodegenerative disorder leading to irreversible loss of neurons, cognition and formation of abnormal protein aggregates. Rivastigmine, a reversible cholinesterase inhibitor used for the treatment of AD, un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b87449663e808ebfe3c50ecb4b2e3ee
https://doi.org/10.3109/10717544.2013.878857
https://doi.org/10.3109/10717544.2013.878857
Publikováno v:
Chronicles of Young Scientists, Vol 2, Iss 2, Pp 111-114 (2011)
Polacrilin potassium (PP), an ion exchange resin, was used as a superdisintegrant to improve the dissolution of rifampicin, from microcrystalline cellulose (MCC) based pellets prepared by extrusion-spheronization. Production of fast release pellets b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f0a137464ebef4829cf0766a0061d3
http://www.cysonline.org/article.asp?issn=2229-5186
http://www.cysonline.org/article.asp?issn=2229-5186
Publikováno v:
European Journal of Pharmaceutics and Biopharmaceutics. 69:769-775
The present work aims to predict drug release from novel site-specific release isoniazid pellets, in USP dissolution test apparatus 3, using the response surface methodology (RSM). Site-specific release isoniazid pellets were prepared by extrusion-sp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b4a1ee75e560ee364b0a9d00eae33a5
https://doi.org/10.1016/j.ejpb.2007.11.020
https://doi.org/10.1016/j.ejpb.2007.11.020
Autor:
Raghun, an P, Jyotish Chandra Samantaray, ey Rm, Rashmita Pradhan, Kamal Kishore, Chamanlal Shishoo, Sanjeev Sinha, Harish Padh, Manish Nivsarkar
Publikováno v:
Mycobacterial Diseases.
Background: Fixed-dose combinations (FDCs) of anti-tubercular drugs have been recommended as a step towards ensuring better treatment and compliance of patients receiving anti-tubercular therapy (ATT). Methods: The study was an open-label and randomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4196e3d511f5bb38d1eb49625f646807
https://doi.org/10.4172/2161-1068.1000157
https://doi.org/10.4172/2161-1068.1000157
Publikováno v:
International journal of pharmaceutics. 411(1-2)
Rifampicin, a first line anti-tubercular drug, has maximum solubility and permeability in the stomach. An oral multi-particulate formulation with site specific sustained delivery of rifampicin was developed. This oral gastroretentive rifampicin formu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b994c1adcc2404f96817bff9201af749
https://pubmed.ncbi.nlm.nih.gov/21458549
https://pubmed.ncbi.nlm.nih.gov/21458549
Publikováno v:
International journal of pharmaceutics. 388(1-2)
In the present study, isoniazid was formulated as site-specific release pellets with high drug loading (65%, w/w) using extrusion-spheronization followed by aqueous coating of Sureteric® (35% weight gain). A statistical experimental strategy was dev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db6e3cc550718f508c524cc8b8bb9a75
https://pubmed.ncbi.nlm.nih.gov/20035851
https://pubmed.ncbi.nlm.nih.gov/20035851
Publikováno v:
ChronoPhysiology and Therapy. :1
Sumit Patil1, Swati Pund2, Amita Joshi2, Chamanlal J Shishoo2, Aliasgar Shahiwala11Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, India; 2Department of Pharmaceutics, BV Patel PERD Centre,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a91535d24d577d4c3c9fd05a47242dc
https://doi.org/10.2147/cpt.s16504
https://doi.org/10.2147/cpt.s16504